FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Progesterone Not Withdrawn Due to Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that progesterone injection, USP, 50 mg/mL, was not withdrawn due to safety or effectivene...

FDA Fast Tracks Invectys IVS-3001

[ Price : $8.95]

FDA approves a fast-track designation for Invectys IVS-3001 antigen to combat renal cell cancer.

Lupin Recalls 2 Lots of Tydemy Contraceptive

[ Price : $8.95]

Lupin Pharmaceuticals recalls two lots of Tydemy oral contraceptive tablets due to out-of-specification test results at the 12-mon...

FDA, DEA Steps to Ease Rx Stimulant Shortage

[ Price : $8.95]

FDA commissioner Robert Califf and DEA administrator Anne Milgram say they are taking multiple steps to ease a shortage of prescri...

Actuate Gets Orphan Status for Pancreatic Cancer

[ Price : $8.95]

FDA grants Actuate Therapeutics an orphan drug designation for elraglusib for treating patients with pancreatic cancer.

FDA Warns Intas About Multiple Violations

[ Price : $8.95]

FDA warns Indias Intas Pharmaceuticals about CGMP and other violations at its drug manufacturing facility in Sanand, India.

Iso-Tex Diagnostics CGMP Issues

[ Price : $8.95]

FDA warns Alvin, TX-based Iso-Tex Diagnostics about CGMP violations in its production of finished drugs.

CGMP Violations at Baxter India Facility

[ Price : $8.95]

FDA warns Baxters Ahmedabad, India-based drug manufacturing facility about CGMP and other violations.

Teleflex QuikClot Device Expanded Use Cleared

[ Price : $8.95]

FDA clears a Teleflex 510(k) for expanded use for the QuikClot Control+ Hemostatic Device mild and moderate bleeding in cardiac s...

GSK Wins Expanded Use for Jemperli

[ Price : $8.95]

FDA approves a GSK supplemental BLA for Jemperli (dostarlimab) in combination with carboplatin and paclitaxel, followed by single-...